These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 23973689)

  • 1. Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study (very large database of lipids).
    Elshazly MB; Martin SS; Blaha MJ; Joshi PH; Toth PP; McEvoy JW; Al-Hijji MA; Kulkarni KR; Kwiterovich PO; Blumenthal RS; Jones SR
    J Am Coll Cardiol; 2013 Nov; 62(21):1960-1965. PubMed ID: 23973689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications.
    Martin SS; Blaha MJ; Elshazly MB; Brinton EA; Toth PP; McEvoy JW; Joshi PH; Kulkarni KR; Mize PD; Kwiterovich PO; Defilippis AP; Blumenthal RS; Jones SR
    J Am Coll Cardiol; 2013 Aug; 62(8):732-9. PubMed ID: 23524048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B).
    Elshazly MB; Quispe R; Michos ED; Sniderman AD; Toth PP; Banach M; Kulkarni KR; Coresh J; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2015 Aug; 132(8):667-76. PubMed ID: 26137953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines.
    Sathiyakumar V; Park J; Quispe R; Elshazly MB; Michos ED; Banach M; Toth PP; Whelton SP; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2018 Jul; 138(3):244-254. PubMed ID: 29506984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile.
    Martin SS; Blaha MJ; Elshazly MB; Toth PP; Kwiterovich PO; Blumenthal RS; Jones SR
    JAMA; 2013 Nov; 310(19):2061-8. PubMed ID: 24240933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-HDL-C goals based on the distribution of population percentiles in ELSA-Brasil: Is it time to change?
    Brito FA; Pedrosa W; Maluf CB; Dos Reis RCP; Fedeli LMG; Castilhos C; Barreto SM; Vidigal PG
    Atherosclerosis; 2018 Jul; 274():243-250. PubMed ID: 29729963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
    Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
    BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method.
    Whelton SP; Meeusen JW; Donato LJ; Jaffe AS; Saenger A; Sokoll LJ; Blumenthal RS; Jones SR; Martin SS
    J Clin Lipidol; 2017; 11(4):1065-1072. PubMed ID: 28826567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17).
    Miller PE; Martin SS; Toth PP; Santos RD; Blaha MJ; Nasir K; Virani SS; Post WS; Blumenthal RS; Jones SR
    J Clin Lipidol; 2015; 9(5):676-83. PubMed ID: 26350814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study.
    Quispe R; Manalac RJ; Faridi KF; Blaha MJ; Toth PP; Kulkarni KR; Nasir K; Virani SS; Banach M; Blumenthal RS; Martin SS; Jones SR
    Atherosclerosis; 2015 Sep; 242(1):243-50. PubMed ID: 26232164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.
    Quispe R; Al-Hijji M; Swiger KJ; Martin SS; Elshazly MB; Blaha MJ; Joshi PH; Blumenthal RS; Sniderman AD; Toth PP; Jones SR
    J Clin Lipidol; 2015; 9(4):511-8.e1-5. PubMed ID: 26228668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving secondary prevention low-density lipoprotein particle concentration goals using lipoprotein cholesterol-based data.
    Mathews SC; Mallidi J; Kulkarni K; Toth PP; Jones SR
    PLoS One; 2012; 7(3):e33692. PubMed ID: 22479428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.
    Martin SS; Giugliano RP; Murphy SA; Wasserman SM; Stein EA; Ceška R; López-Miranda J; Georgiev B; Lorenzatti AJ; Tikkanen MJ; Sever PS; Keech AC; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2018 Aug; 3(8):749-753. PubMed ID: 29898218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia.
    Jacobson TA
    Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance between lipid markers used for predicting cardiovascular risk in patients with type 2 diabetes.
    Modi KD; Chandwani R; Ahmed I; Kumar KV
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S99-S102. PubMed ID: 26589777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis.
    Palmer MK; Barter PJ; Lundman P; Nicholls SJ; Toth PP; Karlson BW
    Clin Biochem; 2019 Feb; 64():24-29. PubMed ID: 30365923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.